T1	Participants 60 132	adults with soft tissue sarcomas of the head and neck, breast, and trunk
T2	Participants 147 382	31 patients were entered in a randomized, prospective study testing the efficacy of adjuvant chemotherapy after aggressive local treatment of high-grade sarcomas of the head, neck, breast, and trunk (excluding retroperitoneal sarcomas)
T3	Participants 384 508	All patients had complete resection of gross tumor and underwent postoperative radiotherapy (6000-6300 rads over 7-8 weeks).
